COVID-19: Guidelines for Our Reopening

Dry Eye Education

Dry Eye is a chronic and progressive disease and without treatment it can worsen over time. Dry eye sufferers experience great discomfort and traditional therapies may only provide limited symptomatic relief without addressing the root cause. The two predominant forms of dry eye are aqueous deficient (which is relatively rare) and lipid deficient which affects up to 86% of dry eye sufferers. With recent studies from around the world, leading experts conclude that Meibomian Gland Disease (MGD) is the leading cause of dry eye disease. With this new understanding, physicians can treat the primary cause of dry eye rather than just treating the symptoms.

Common signs or symptoms of dry eye caused by MGD are:
  • Burning and redness
  • Ocular fatigue
  • Foreign body sensation
  • Sensitivity to light
  • Excessive tearing
  • Symptoms worsen later in the day
  • Transient blurring
  • Contact lens intolerance

MGD can be asymptomatic in the early stages but can still be diagnosed due to recent advances. As is typical of most treatable diseases, the earlier it is detected, the better chance of preventing further loss of function.

Your TearScience® Evaluation

Using the Lipiview II with Dynamic Meibomian Imaging (DMI) your physician is able to assess both meibomian gland function and structure to detect MGD in its earliest stages. The LipiView interferometer is the first device of its kind that enables eye doctors to assess your tear film by capturing images that measure the thickness of the lipid (oil) component. Next is a closer look at what is happening at the gland level. With the use of the Meibomian Gland EvaluatorTM your doctor can examine the quantity and quality of lipids being release from your glands. The TearScience evaluation is part of your overall Dry Eye assessment. Knowing what is causing your Dry Eye will help your doctor determine your best treatment option.

LipiFlow®: A Different Approach

LipiFlow® is a new procedure designed to treat the root cause of Evaporative Dry Eye, blocked Meibomian glands. Opening and clearing these blocked glands can allow them to resume natural production of lipids (oils) needed for a healthy tear film.

At the heart of the LipiFlow® Thermal Pulsation System is the Activator (eyepiece). The Activator uses patented, precisely controlled heat applied to the inner eyelid with adaptive pressure encouraging your body to resume the natural production of lipids (oils) needed for your tear film. Its single-use design and built-in sensors ensure a safe, sterile treatment. The treatment is performed in our office.

Studies show 79% of patients report improvement of their overall dry eye symptoms within four weeks.

Ask your doctor about Lipiflow, a revolutionary technology backed by over 25 years of scientific research that may be able to bring back comfort to your life.

Map Map